Immune cells among TME are associated with the hallmarks of BC 3, we continued to evaluate the biomarker relevance of SLC3A2 compared to standardized cancer biomarkers in immune checkpoint blockade sub-cohorts using TIDE database. The gene discussed is SLC3A2; the disease is cancer.